Page de couverture de Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan

Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan

Pharmaceutical Executive Daily: Alkermes' CEO Succession Plan

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

In today’s Pharmaceutical Executive Daily, Alkermes outlines its CEO succession plan following Richard Pops’ retirement announcement, leadership changes continue at Sarepta Therapeutics and Rivus Pharmaceuticals, and Boehringer Ingelheim secures an exclusive license for a preclinical small-molecule program.
Pas encore de commentaire